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Abstract: Modifications found in the Anticodon Stem Loop (ASL) of tRNAs play important
roles in regulating translational speed and accuracy. Threonylcarbamoyl adenosine (t6 A37) and
5-methoxycarbonyl methyl-2-thiouridine (mcm5 s2 U34) are critical ASL modifications that have been
linked to several human diseases. The model yeast Saccharomyces cerevisiae is viable despite the
absence of both modifications, growth is however greatly impaired. The major observed consequence
is a subsequent increase in protein aggregates and aberrant morphology. Proteomic analysis of the
t6 A-deficient strain (sua5 mutant) revealed a global mistranslation leading to protein aggregation
without regard to physicochemical properties or t6 A-dependent or biased codon usage in parent genes.
However, loss of sua5 led to increased expression of soluble proteins for mitochondrial function,
protein quality processing/trafficking, oxidative stress response, and energy homeostasis. These results
point to a global function for t6 A in protein homeostasis very similar to mcm5 /s2 U modifications.
Keywords: tRNA modification; protein aggregation

1. Introduction
Modifications of the four canonical bases found in the Anticodon Stem Loop (ASL) of tRNAs are
critical for optimal decoding of mRNAs [1,2]. ASL modifications influence both decoding efficiency [3–5]
and accuracy [6–8]. The roles of ASL modifications in decoding are complex and vary with the type of
modification, its position in the ASL, the specific codon, and the organism [2]. To add to this complexity,
the effect of a given modification is influenced by the codon context [9] and by the presence/absence of
other modifications [10,11]. Deficiencies in the synthesis of many ASL modifications have been linked
to disease of protein homeostasis in humans leading to a wide range of pathologies such as familial
dysautonomia, nonsyndromic X-linked intellectual disability or microcephaly [12].
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in multi-subunit complexes: the KEOPS complex for t66 A synthesis [33] and the Elongator complex
multi-subunit complexes: the KEOPS complex for t A synthesis [33] and the Elongator complex
(Elp1–Elp6) for mcm5 U5[28,34]. While the mechanistic aspects of their synthesis are still being elucidated,
(Elp1–Elp6) for mcm U [28,34]. While the mechanistic aspects of their synthesis are still being
most genes involved have been identified [32] and the pathways have been reconstituted fully [23]
elucidated, most genes involved have been identified [32] and the pathways have been reconstituted
or partially [35,36] in vitro. This has allowed researchers to dissect the role of these modifications
fully [23] or partially [35,36] in vitro. This has allowed researchers to dissect the role of these
in vivo, where it has become apparent that defects in mcm5 s2 U34 and t6 A37
synthesis in yeast gives
modifications in vivo, where it has become apparent that defects in mcm5s2U34 and t6A37 synthesis
rise to very similar phenotypes, including activation of the Gcn4 General Amino Acid Control (GAAC)
in yeast gives rise to very similar phenotypes, including activation of the Gcn4 General Amino Acid
response independently of Gcn2 and sensitivity to similar stresses [3,29,37]. The activation of the
Control (GAAC) response independently of Gcn2 and sensitivity to similar stresses [3,29,37]. The
Gcn4 response seems to be a general response to tRNA modification deficiency in yeast as it was also
activation of the Gcn4 response seems to be a general response to tRNA modification deficiency in
observed in the absence of seven other modifications [9], but some of these cases have been shown to be
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in part Gcn2 dependent [38]. t6 A37 and mcm5 s2 U34 are not positive determinants for their respective
synthesis machineries, as the absence of one modification does not affect the presence of the other [39].
The t6 A phenotypes are not suppressed by overexpression of any individual tRNA [39], whereas
overexpressing tRNAGln UUG and tRNALys UUU is sufficient to suppress most phenotypes caused by the
absence of mcm5 s2 U34 [40]. In terms of the fine-tuning of translation speed, as measured by ribosome
profiling, the absence of mcm5 s2 U34 in tRNAs leads to a clear reduction of translation speed at the
cognate codons [4] consistent with its role in cognate codon binding that prevents tRNA rejection
during ribosomal proofreading [41,42]. However, the response to t6 A deficiency appears to be more
nuanced, as translation speed increases or decreases depending on the specific codon [39]. While the
absence of both modifications affects +1 frameshifting [24,41], they demonstrate different effects on
misreading [36,43]. For example, the presence of t6 A reduces misreading at UAG and UAA termination
codons but increased misreading at error-prone codons. These effects were mostly independent of the
presence of the mcm5 modification. Both mcm5 and s2 modification defects increase the misreading of
the GGA Gly codon by tRNAGlu UUC but have weaker effects on other mismatches.
A central theme emerging from studies of ASL modifications deficiencies involves a general
disruption of proteome integrity and an increase in protein aggregation [2,44]. For instance, it is
known that perturbations of translation speed can lead to protein misfolding directly by affecting
co-translational folding [4,45], or indirectly through misincorporation of erroneous amino acids [45].
Accordingly, the absence of mcm5 U and mcm5 s2 U in yeast and C. elegans, as well as the absence of t6 A
in yeast, has been shown to induce the formation of cellular protein aggregates [4,39,44]. In the case
of mcm5 s2 U, strongly enhanced aggregate formation has been observed in the context of mutations
that affect both mcm5 U and s2 U synthesis [4]. Aggregation phenotypes have also been observed in
the absence of other tRNA modifications, such as queuosine (Q34) or m2 2 G26 in mammals [5,46,47].
The Unfolded Protein Response (UPR) is activated by t6 A deficiency in higher eukaryotes [48] or
mcm5 U deficiency in different eukaryotic models but only mcm5 U deficiency activates the UPR in
S. cerevisiae [44,49]. Transcriptome analysis of yeast deficient in t6 A reveals no UPR response [39],
which is actually reduced in the absence of mcm5 s2 U in this strain [49]. Despite a growing body of
research, few studies have systematically analyzed how the absence of tRNA modification affects the
aggregation of yeast prions [50,51]. One would expect that the translation of the stretches of identical
amino acids found in these specific proteins [52] is particularly sensitive to reduced translation speed.
Indeed, synthesis of the Gln-rich prion Rnq1 is severely impaired by the absence of mcm5 s2 U34 and
this defect can be rescued by overexpression of tRNAGln UUG [29], but it is not known if the absence of
t6 A affects the synthesis of the Asn/Thr rich prion SWI1 [53].
Several examples suggest a collaboration of different anticodon loop modifications in the
maintenance of tRNA function [10,11,16,29,54]. Regarding the (c)t6 A37 and mcm5 (s2 )U interactions,
synthetic effects of partial loss of mcm5 s2 U or the cyclic form of t6 A (ct6 A) on yeast cell growth
have been observed [29]. If the prevention of t6 A cyclization in tcd1 mutants did not result in strong
aggregate induction, a combination of such defects with mcm5 U or s2 U deficiency did [29]. However,
the combination of U34 hypomodification with the absence of t6 A37 modification has never been
studied, in part due to severe growth defects caused already by the loss of t6 A alone [39]. In this
work, we report that an S. cerevisiae strain lacking both t6 A and mcm5 /s2 U34 modifications is greatly
affected in growth and morphology, with an observed synthetic lethality in specific conditions, as well
as additive effects in protein aggregation and +1 frameshifting phenotypes. As the proteomic analysis
of t6 A deficiency has previously only been performed in bacteria [55], we also compared soluble and
insoluble (or “aggregated”) fractions of the yeast proteome between WT and t6 A-deficient strains.
Our proteomic results describe the consequences of perturbing translation through ASL modification
deficiency and provide insights into correlating shifts in codon usage.

Biomolecules 2020, 10, 322

4 of 24

2. Materials and Methods
2.1. Strains, Plasmids and Growth Assays
The strains used and generated in this study are listed in Table 1. Gene replacements were
verified with forward/reverse primers positioned outside of the target loci (Supplemental Table S1).
Cultivation of the different strains with yeast nitrogen base (YNB)/yeast peptone dextrose (YPD) as
well as yeast transformations were performed using standard methods [56]. A BY4741 elp3::SpHIS5
mutant was generated by marker swap using BY4741 elp3::KANMX4 and pUG27 [57]. GFP tagging
of HSP104 was done using pFA6a-GFP-natMX [58]. Crosses were done by patching haploid BY4742
(MATα lys2) derived and BY4741 (MATa met15) strains on –Met –Lys media. Heterozygous diploids
were first subcloned on selective minimal media, then on YPD and finally put on sporulation media
(20 g/L potassium acetate, 1 g/L glucose, 2.5 g/L yeast extract 20 g/L agar plus required supplements
to cover auxotrophic markers). Sporulation was monitored microscopically. Cells were recovered
from sporulation plates and resuspended in 200 µL sterile water to which 5 to 20 µL zymolyase stock
solution (zymolyase 20T, 5 mg/mL) was added. Following incubation for 5 to 10 min at 37 ◦ C, 1 mL
of ice-cold sterile water was added, and 20 µL of digested cells placed on the edge of a YPD plate.
Tetrads were dissected using a Singer MSM400 micromanipulator (Singer instruments, Roadwater,
Watchet, UK) and genotypes of individual spores assessed by diagnostic PCR analysis and checking
auxotrophic markers and G418 resistance on appropriate media.
Table 1. Saccharomyces cerevisiae strains used in this study.
Strain

Genotype

References/Sources

BY4741

MATa, his3∆, leu2∆, met15∆, ura3∆

Euroscarf, Frankfurt

BY4742

MATα, his3∆, leu2∆, lys2∆, ura3∆

Euroscarf, Frankfurt

Y02742

BY4741 elp3::KANMX4

Euroscarf, Frankfurt

RK311

BY4741 HSP104-GFP::natMX6

This study

RK477

BY4741 elp3::SpHIS5

This study

VDC9100

BY4742 sua5::KANMX4

[59]

Y07017

BY4741 gon7::KANMX4

Euroscarf, Frankfurt [39]

RK340

BY4742 sua5::KANMX4
elp3::SpHIS5

This study

RK357

BY4742 sua5::KANMX4
elp3::SpHIS5 HSP104-GFP::natMX6

This study

RK359

BY4742 elp3::SpHIS5
HSP104-GFP::natMX6

This study

RK360

BY4742 sua5::KANMX5
HSP104-GFP::natMX6

This study

LPO0180

BY4741 pJMB21

This study

LPO0181

BY4741 pJMB21::SWI1

This study

LPO0085

BY4742 sua5::KANMX5 pJMB21

This study

LPO0087

BY4742 sua5::KANMX5
pJMB21::SWI1

This study

LPO0089

BY4741 gon7::KANMX5 pJMB21

This study

LPO0091

BY4741 gon7::KANMX5
pJMB21::SWI1

This study
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2.2. Plasmid Construction
pYX142-mtGFP [60] was used as a backbone for the construction of pJMB21. To monitor expression
on both the N- and C-terminal ends, a HA-tag flanked by two new multiple cloning sites (MCS)
were introduced into pYX142-mtGFP (Figure S1). This new construct allowed for the expression of
proteins containing an N-terminal HA-tag with a C-terminal GFP fusion. Gene synthesis and plasmid
construction were sourced through GenScript (Order 702065-3). The N-terminal end of SWI1 (residues
1-556) was synthesized (GenScript) and inserted into pJMB21 between the SbfI and AscI restriction
sites to give plasmid pJMB21::SWI1.
2.3. Detection of HA-SWI1-GFP Fusion in t6 A Deficient Strains
Competent wild-type (BY4741) and two t6 A deficient strains (gon7 and sua5 mutants) were
transformed with pJMB21 and pJMB21::SWI1 using the Frozen-EZ Yeast Transformation II Kit (Zymo
Research, Cat#T2001, Irvine, CA, USA) and selected in minimal synthetic defined base (SD) with
dropout supplements (-leucine) (SD-Leu) (Takara, Cat# 630,411 and 630414, Mountain View, CA, USA).
The transformants were grown overnight and sub-cultured in SD-Leu to reach the early exponential
phase (OD600 of 0.6). The cell pellets were stored at −80 ◦ C until protein extracts were prepared.
The cell pellets were resuspended in water and normalized based on the OD600 (equivalent to 5 mL
culture at OD600 0.6). To facilitate the permeabilization of yeast cells, the pellets were washed in 2 M
LiOAc and then in 0.4 M NaOH (kept 5 min on ice with each solution) [61]. Extracts were prepared
by boiling the cells for 10 min in 200 µL of SDS loading buffer (10% SDS, 250 mM Tris-Cl pH 6.8,
500 mM DTT, 25% glycerol, bromophenol blue) and then loaded (12 µL/well) in 12% acrylamide gel.
For Western blot, proteins were transferred to a PVDF membrane and probed with 1:1000 HA Epitope
Tag Antibody, HRP conjugate (Thermo Fisher Scientific, Cat# 26183-HRP, Rockford, IL, USA).
2.4. Detection of Protein Aggregates by Different Methods
Protein aggregates were first isolated as described previously [29]. Cell pellets were obtained from
50-mL YPD cultures of BY4742 derivatives grown to OD600 = 1.0. Cells were broken by sonication and
4 mg total protein was subjected to centrifugation and washing [29]. The remaining aggregate pellet
was subsequently boiled in SDS sample buffer and separated on NuPAGE Bis-Tris 4–12% gradient gels.
For comparison, 25 µg total protein was separated on identical gels.
For visualization of aggregates within cells, strains expressing a GFP tagged variant of the
aggregate binding protein Hsp104 were generated by genomic tagging of HSP104 and subsequent
crossing to sua5 elp3 followed by tetrad dissection. WT and sua5/elp3 single and double mutant strains
carrying the genomic HSP104-GFP fusion were grown to log phase, washed twice in sterile water and
visualized in phase contrast and fluorescence optics using an Olympus BX53 microscope (Olympus,
Hamburg, Germany).
The final method to quantify protein aggregation used [35 S]-labeling. BY4742 cells (WT, sua5
mutant, and sua5 elp3 double mutant) were grown from a single colony in 10 mL of complete medium
lacking Met and Cys with 5 µL of 100 mM Met and Cys added (50 µM final). Overnight cultures were
diluted to 0.1 OD600 in 5 mL of complete medium lacking Met and Cys with the addition of 2.5 µL of
100 mM Met and Cys (50 µM final) and 3 µL (33 µCi) of [35 S]-Met and of [35 S]-Cys. The three strains
grew at different rates, so cultures were grown to a constant optical density (1.2 OD600 ), which required
7 h for WT, 26 h for sua5, and 68 h for sua5 elp3. Three normalized aliquots for each strain (equivalent
to OD600 = 1.5 per mL) were prepared as technical replicates. Cells were pelleted by centrifugation
at 7000× g for 10 min at 4 ◦ C and 600 µL of the supernatant was removed; the remainder of the
supernatant was discarded. One-half of the supernatant (300 µL) was placed in a 3000 Dalton spin filter
and centrifuged for 10 min at 16,100× g at 4 ◦ C. The 300 µL of remaining input and the flow-through
were saved for scintillation counting. To the retentate in the spin filter, 300 µL of PBS was added and
the sample centrifuged for 10 min at 16,100× g, with the flow-through discarded. This was repeated
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one time. The empty 3000 Dalton spin filter membrane was saved for scintillation counting. To the cell
pellet remaining from above 600 µL of PBS was added and the pellet was resuspended. Following
centrifugation at 7000× g for 10 min at 4 ◦ C, the supernatant was discarded, the pellet washed again
with 600 µL of PBS, discarding the supernatant. The cell pellet was resuspended in 700 µL of PBS and
5 µL of lyticase (50 units) was added with mixing and incubation at RT for 40 min. The samples were
then transferred to MP Bio Lysing Matrix C (1.0 mm) tubes and caps were tightened tightly. Samples
were processed on a Thermo FastPrep (FP120) bead-beater 3 times at speed 6.0 for 30 s with a 30 s
pause between runs. Samples were then centrifuged at 200× g for 10 min at 4 ◦ C to remove glass beads
and the supernatant was transferred to 2 mL plastic tubes, to which 300 µL of PBS was added and the
samples vortexed. Following centrifugation at 200× g for 10 min at RT, the supernatant was transferred
to 2 mL plastic tubes and the glass beads were saved for scintillation counting. The supernatants were
now centrifuged at 16100× g for 10 min at RT and the new supernatants transferred to new 2 mL plastic
tubes and the pellets in original tubes saved for scintillation counting. The new supernatants were
again centrifuged at 16,100× g at RT to completely clear the samples before transferring supernatant
to a 3000 Dalton spin filter followed by centrifugation at 16,100× g for 10 min at RT. The remaining
supernatant and the flow-through from the 3000 Dalton spin filter were saved for scintillation counting.
All samples were subjected to scintillation counting in an LS 6500 Beckman Coulter Scintillation
counter. Scintillation counting data were normalized to total protein levels measured by the BCA
Assay (Bio-Rad, Hercules, CA, USA).
2.5. Proteomic Analyses
2.5.1. Isolation of Soluble and Insoluble Proteins
Soluble and insoluble protein fractions were isolated from yeast cells as described by Koplin et al.,
2010, with a few modifications [62]. Briefly, logarithmically growing cells cultivated in MM-His
(50 OD600 units) were harvested at 200× g for 10 min at 4 ◦ C and the resulting cell pellets were washed
with ice-cold phosphate-buffered saline (PBS) and frozen at −80 ◦ C. To prepare cell lysates, pellets were
resuspended in 500 µL of lysis buffer (20 mM Na-phosphate, pH 6.8, 10 mM DTT, 1 mM EDTA, 0.1%
v/v Tween, 1 mM PMSF, Roche protease inhibitor cocktail, 3 mg/mL lyticase and 1.25 U/mL benzonase),
and incubated at 30 ◦ C with mild shaking for 30 min. Glass beads were used to disrupt cells using
a Precellys 24 disrupter; 2 cycles of 25 s at 6500 rpm; samples were kept on ice between each cycle. Cell
lysates were then centrifuged for 20 min at 200× g at 4 ◦ C and supernatant fractions were aspirated,
analyzed by the BCA method [63] and adjusted to equimolar protein concentrations (4.8 mg/mL for
protein gels and 4 mg/mL for LC-MS/MS analysis) across samples. Membrane and aggregated proteins
were isolated from this supernatant fraction by centrifugation at 16,000× g for 20 min at 4 ◦ C. Following
this round of centrifugation, resulting supernatant fractions were aspirated and membrane proteins
were removed by resuspending aggregated proteins in 2% NP-40 (in 20 mM Na-phosphate, pH 6.8,
1 mM PMSF and Roche protease inhibitor cocktail), disrupting the mixture by probe sonication (6-times
for 5 s at cycle 0.1 and amplitude 20%), and centrifuging the mixture at 16,000× g for 20 min at 4 ◦ C.
This process was repeated twice, after which final insoluble protein fractions were washed with buffer
lacking NP-40 (probe sonication, 4-times for 5 s at cycle 0.1 and amplitude 20%). For electrophoretic
analyses, the pellets and samples of soluble proteins were boiled in 1X Laemli sample buffer, separated
by SDS-PAGE (14%), and resolved by Coomassie staining. For LC-MS proteomics analyses, samples of
soluble proteins and insoluble protein aggregates were precipitated with TCA (100% w/v) by adding 1
volume of TCA to 4 volumes of protein solution followed by incubation at 4 ◦ C for 30 min. Precipitated
protein samples were washed with 200 µL of ice-cold acetone (9:1 v/v), and pellets were allowed to air
dry at RT. Dried protein pellets were resuspended in 1 mL of 10 mM TEAB and quantified by BCA
Assay (Bio-Rad) before further processing for MS/MS analysis.
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2.5.2. Protein Processing, Labeling with Isobaric Tags, and Peptide Fractionation
Protein samples were aliquoted (100 µg per sample), dried by vacuum centrifugation, reconstituted
in 100 mM TEAB and 10% acetonitrile (v/v) by bath sonication, and digested with trypsin in a 1:30
(w/w) ratio overnight at 37 ◦ C. Aliquots of resulting protein digests (from 100 µg of total protein) were
then labeled with TMT 6-plex reagents according to the manufacturer’s protocol. Labeled peptides
(5-µL aliquots) from each biological replicate were combined to reconstitute a full 6-plex label set
and subjected to preliminary qualitative analysis on a Thermo Scientific EASY-nLC 1200 interfaced
to a Thermo Scientific Q Exactive Hybrid Quadrupole-Orbitrap mass spectrometer (Thermo Fisher
Scientific, Waltham, MA, USA) Median total ion intensities for each label were calculated and used to
normalize volumetric mixing of respective labels, so as to avoid signal suppression or bias from any
one label. After combining labels into 6-plex sets, samples were desalted with C18 SpinTips (Protea),
dried by vacuum centrifugation, and reconstituted in IPD buffer (Agilent) without glycerol. Isoelectric
focusing was performed from pH 3 to 10 over 24 wells on an Agilent 3100 OFFGEL fractionator
according to the manufacturer’s protocol (OG24PE00). Each of the 24 fractions was collected, dried by
vacuum centrifuge, resuspended in 0.1% formic acid in water, and analyzed by nano-LC-MS/MS.
2.5.3. LC-MS Analysis of the Aggregated Yeast Proteome
TMT proteomics experiments were performed on an Agilent 1200 nano-LC-Chip/MS interfaced to
an Agilent 6550 iFunnel Q-TOF LC/MS. The LC system consisted of a capillary pump for sample loading,
a nanoflow pump, and a thermostated microwell-plate autosampler. The HPLC-Chip configuration
consisted of a 160-nL enrichment column and a 150 mm × 75 µm analytical column (G4340-62001
Zorbax 300SB-C18). The following mass-spectrometry grade mobile phases (Burdick & Jackson) were
used: 0.1% formic acid in water (solvent A), and 0.1% formic acid in acetonitrile (solvent B). A 130-min
linear gradient was used for HPLC separation with 10 min for column washing and equilibration
between runs. Samples (1–2 µL injections) were loaded onto the enrichment column at 3% (v/v) B at
flow rates of 3 µL min-1. The analytical gradient of solvent B was performed at a constant flow rate of
0.3 µL min-1 using the following solvent transitions on the nanoflow pump: 0–1 min, held at 1% (v/v);
1–10 min, 1–15%; 10–101 min, 15–35%; 101–121 min, 35–75%; 121–123 min, 75–98%; 123–126 min, held
at 98%; 126–127 min, 98–1%; 127–130 min, held at 1%. The Q-TOF was operated at high sensitivity
(4 GHz) in positive ion mode with the following source conditions: gas temperature 350 ◦ C, drying gas
13 L min-1, fragmentor 360 V. Capillary voltage was manually adjusted between 1800 to 2150 V to
maintain a steady nanospray plume. Data were acquired from 300 to 1700 m/z with an acquisition rate
of 6 spectra s−1 in MS mode, and from 50 to 1,700 m/z with an acquisition rate of 3 spectra s−1 in MS/MS
mode. A peptide isotope model (charge state 2+) was used to detect a maximum of 20 precursors per
cycle at a minimum threshold of 25,000 counts/spectra at a narrow isolation window (~1.3 m/z). Sloped
collision energy (C.E.) was used to maximize collision-induced dissociation of detected isobarically
tagged peptides according to the following rules: charge state 2+ C.E. slope 4.2, offset 3.5; charge states
≥ 3+ C.E. slope 4.2, offset 4.
LC-MS data were extracted and evaluated for quality using the MFE algorithm in MassHunter
Qualitative Analysis software (v B06.00). Test injections (3–4) from each fraction of the first technical
replicate were used to optimize injection volumes for second and third biological replicates with the
aim of maximizing the number of extracted molecules with peptide-like features. For each fraction,
the MFE list of molecular ions was exported and used to exclude the spectral acquisition of these ions
in subsequent technical replicates. Each of the 24 fractions from biological triplicates was injected in
technical duplicate—spectra generated from technical replicate #1 were acquired without the use of
an exclusion list, whereas spectra generated from technical replicates #2 and #3 were acquired with the
exclusion list. Data from MassHunter Qualitative Analysis was exported to Mass Profiler Professional
(v B03.00) for analysis of technical reproducibility. This process was repeated for all three biological
replicates. Mass spectra were processed using Spectrum Mill (Agilent, v B06.00) and Scaffold Q+ (v
Scaffold_4.8.8), and quantified protein associations were manually analyzed by binning and averaging
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peptide quantities across related protein groups in Excel. For the insoluble fraction, this analysis
produced 327,549 spectra that were assigned to 6421 identified S. cerevisiae proteins (peptide threshold:
< 1% FDR) and 5109 proteins with quantifiable peptides across all three biological replicates (protein
threshold: > 99% confidence, min 2 peptides). The soluble fraction yielded 42,611 spectra assigned
to 4890 identified S. cerevisiae proteins, of which 3814 were quantifiable across all three biological
replicates. Proteomics data are available at Chorus Project (https://chorusproject.org/pages/index.html).
2.5.4. Proteomics Data Analysis
Proteomics data were used to calculate fold-change values (sua5/WT) for the sets of soluble
and insoluble proteins. Differentially expressed proteins in WT and sua5 were then analyzed for
various physicochemical properties using either Saccharomyces Genome Database data (https://www.
yeastgenome.org) or publicly available datasets: isoelectric point [64], codon adaptation index [65],
protein half-life [66,67], protein abundance [66,68], molecular weight [69], and hydrophobicity [69].
Total proteins in each fraction and differentially expressed proteins were analyzed for Gene Ontology
category enrichment [69].
2.5.5. Codon Usage Analysis
Gene-specific codon usage data detailing the number of times each codon was used in a gene
and the frequency of each codon, relative to other codons for the same amino acid in said gene, was
previously described [70]. Codon frequency trends for sets of transcripts were determined by taking
the average frequency value of each codon in the group. The number of times a specific dicodon
was found in each gene was determined using slight modifications to the original GSCU algorithm
developed for gene-specific (mono) codon usage analysis [71]. Briefly, each gene was analyzed from
start to stop codon for the instance of a specific two codon combination, data were tabulated for each
gene, and then the next gene was analyzed. The resulting dicodon data were then sorted into groups
genes with identical instances of specific dicodon combinations and graphed in Excel. Gene ontology
analysis was performed using utilities found in STRING (https://string-db.org/) [71].
2.5.6. Statistical Analyses
Differentially expressed proteins were determined using one-way ANOVA using Bonferroni
multiple testing correction. Differential abundance of proteins was analyzed by a random-effects
Bayes model using the BETR algorithm in MeV (http://www.tm4.org/mev.html). Interpretations of the
relationships between codon usage predictors (codon frequency) and protein up-or down-regulation
(log2 mean fold-change) were analyzed using a partial least squares regression (PLSR) algorithm in The
UnscramblerX (v10.4, CAMO Software). Outlier loadings that could cause over-fitting were removed
by inspection of variable residuals and leverages. Validation was performed using cross-validation
and the significance of variables determined by Marten’s uncertainty test. The Root Mean Square Error
of Prediction (RMSEP), slope, and correlation coefficient of predicted versus measured correlation line
were used to evaluate the efficiency of the applied regression model.
2.6. Whole-Cell Analyses
For microscopic detection of nuclei, cells were first fixed in 70% ethanol for 10 min and subsequently
resuspended in 1 µg/mL 40 ,6-diamidino-2-phenylindole (DAPI). After incubation for 1 h in the dark,
cells were washed with sterile water and observed in phase contrast and fluorescence optics using
an Olympus BX53 microscope. +1 frameshift assays utilized constructs with the frameshift site
CUU-AAA-C [72] and were carried out as described previously [49].
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3. Results
3.1. Absence of t6 A and mcm5 U Leads to Additive and Possibly Synergistic Translation Defects
S. cerevisiae strains carrying a deletion in ELP3, which encodes the catalytic subunit of the Elongator
complex, lack mcm5 U in tRNA [28] while strains with deletions of SUA5 encoding the first enzyme
of the t6 A synthesis pathway, threonylcarbamoyl-AMP synthase, lack t6 A [25]. To test whether elp3
and sua5 mutations are in fact synthetically lethal, we sporulated a heterozygous sua5 elp3 double
mutant (Figure 2A). Spores containing both mutant alleles are able to germinate but form visible
colonies only several days after the appearance of colonies from spores without the sua5 allele alone.
Serial dilution growth assays indeed revealed a further enhanced growth defect of the sua5 elp3 strain
as compared to the sua5 single mutant (Figure 2B). Microscopic analysis of cell shape and nuclei
distribution revealed morphological defects and mis-segregated nuclei in the sua5 elp3 (Figure 2C).
In addition, the obtained sua5 elp3 strain is unable to grow in the presence of various exogenous
stressors such as elevated temperature, diamide, or alternative carbon sources (Figure 2B,D). As the
presence of mcm5 s2 U in yeast tRNALys UUU suppressed +1 frameshift events, and t6 A is also involved
in reading frame maintenance [24,72], we analyzed a potential cumulative effect on +1 frameshift
levels in the generated sua5 elp3 mutants. We utilized the previously described frameshift sequence in
which a +1 ribosomal shift can be induced by weakened A-site binding of tRNALys UUU [72]. In both
sua5 and elp3 single mutants, elevated +1 shift levels were observed, which further increase in the sua5
elp3 double mutant (Figure 3). Thus, mcm5 s2 U and t6 A indeed independently contribute to reading
frame maintenance.
3.2. The Absence of both ASL Modifications Drastically Increases Formation of Protein Aggregates
Hence, we speculated that the absence of t6 A and mcm5 /s2 U in the generated sua5 elp3 strain
would result in a further increase of protein aggregation if aggregates result from ribosomal pausing
and pausing results from tRNA A-site binding deficiency. As the +1 frameshift measurements are
consistent with cumulative A-site binding defects of tRNALys UUU in sua5 elp3, a cumulative effect on
protein aggregation could be expected if the latter indeed occurs because of the A-site binding defect.
To test this, we utilized a previously established aggregate enrichment protocol [62] and compared
amounts of aggregated proteins in wild type, sua5, and elp3 single mutants with the double mutant.
As shown in Figure 4A, there is indeed a strongly increased amount of protein aggregates in the
double mutant.
Cellular protein aggregates were previously visualized using GFP tagged Hsp104, an aggregate
binding chaperone [73,74]. To address Hsp104 localization in the sua5 elp3 strain which accumulates
protein aggregates, we introduced an HSP104-GFP allele into this background and compared GFP
signals between wild type and the mutant. The wild-type shows a GFP signal typical of the known
nucleo-cytoplasmic distribution and only rarely shows small bright foci indicative of cytoplasmic
protein aggregation [75] (Figure 4B). In the sua5 elp3 mutant, however, bright signal accumulations
were observed particularly in morphologically aberrant cells, with aggregates often being extended
along the axis of polarized growth and encompassing two or more of the non-separated individual cells
(Figure 4B). This may indicate that aggregate formation and extension from the mother into the daughter
cell may contribute to the repeated failures in cytokinesis. Similar Hsp104 signal accumulations and
morphologically aberrant cells were occasionally detectable for the sua5 single mutant as well but not
for an elp3 single mutant (Figure S2).
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Figure 2. Synthetic phenotypes in the genetic background of sua5 elp3 mutants. (A) Tetrad analysis of
a sua5::KANMX4/SUA5 elp3::SpHIS5/ELP3 diploid strain, generated by crossing BY4741 elp3::SpHIS5 and
BY4742 sua5::KANMX4. The genotype of indicated spores was determined by phenotypic analysis (-HIS
media, G418 media) and diagnostic PCR. G418R: Geneticin resistance; HIS+: Histidine prototrophy.
(B) Serial dilution spot assay of indicated strains on YPD plates, which were incubated at 30 ◦ C, 37 ◦ C,
or 39 ◦ C for 48 h. (C) Elongated bud morphology and nuclear segregation defect of the sua5 elp3 strain.
Cells were ethanol fixed and stained with DAPI before phase-contrast and fluorescence microscopy.
(D) Serial dilution spot assay of indicated strains on YPD, YPD containing 0.6 mM diamide, yeast
peptone galactose or yeast peptone glycerol medium. Plates were photographed after the indicated
incubation times.

Biomolecules 2020, 10, 322

11 of 24

Figure 3. Programmed +1 frameshifts are triggered in the sua5 elp3 mutant. (A) Schematic representation
of the utilized +1 frameshift reporter constructs harboring a tRNALys UUU dependent frameshift
site [49,72]. In the event of diminished A-site binding activity of tRNALys UUU , tRNAAsn GUU may
instead read the Asn codon in the +1 shifted reading frame, ultimately allowing expression of the
reporter LacZ which is in the +1 frame relative to the Lys AAA codon. (B) Measurement of +1 frameshift
rates by employing the reporter described in (A) and a control construct, as detailed previously [49,72].
These assays were conducted on three independent cultures per strain and each culture measured
using two technical replicates.

To more accurately assess tRNA modification-dependent protein aggregation and translation in
general, we used [35 S]-labeled methionine and cysteine to quantify protein expression in WT, sua5,
and sua5 elp3 strains. The significantly different growth rates of the strains were accommodated by
growing cultures to the same optical density and then isolating and quantifying [35 S] in soluble and
insoluble proteins in the strains. As shown in Supplementary Figure S3A, the three yeast strains
showed progressively diminishing [35 S] in soluble and insoluble proteins in all fractions in the order
WT > sua5 > sua5 elp3. However, total protein concentration in the soluble fractions was similar for
the three strains (Supplementary Figure S3B). Coupled with similar [35 S] labeling in all fractions, this
suggests that incorporation of [35 S]-labeled Met and Cys was reduced in the two mutant strains. This is
supported by the observation of reduced [35 S] labeling of proteins in SDS-PAGE gels run with samples
normalized for either protein concentration or [35 S] content: the amount of [35 S] signal per unit protein
is highest in WT and progressively reduced in the mutant strains (Supplementary Figure S3C). This
unexpected dilution of the specific activity of [35 S] obviates the use of [35 S] labeling to quantify protein
aggregation differences among the strains.
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Figure 4. Aggregate formation in the sua5 elp3 double mutant. (A) Protein extracts of indicated strains
were generated and analyzed by SDS PAGE before (total protein) and after enrichment of aggregates,
as described previously [4,29]. Aggregates were isolated twice from each strain. Note that the method
used for the solubilization of aggregated proteins used here is not as harsh as that used for the [35 S]
labeling and proteomics analyses (Figure S3). (B) Expression Hsp104-GFP from its natural genomic
locus in WT and sua5 elp3 backgrounds. The HSP104-GFP allele was introduced into sua5 elp3 by
crossing and tetrad dissection.

3.3. Loss of t6 A Leads to Global Defects in Protein Folding and Mitochondrial Assembly
To obtain a more granular view of the effects of loss of t6 A on translation, we performed
a quantitative analysis of the soluble and aggregated (insoluble) proteomes of WT and sua5 strains
(the elp3 sua5 mutant being too crippled for reproducible proteomic analysis). Protein aggregates
were isolated by several rounds of sonication and differential centrifugation of cell lysates using the
detergent buffer. Subsequent TMT-based quantitative proteomics resulted in the coverage of 60–80% of
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the yeast genome, with 3813 proteins quantified in the soluble fraction, 5108 proteins quantified in the
insoluble fraction, and 1864 proteins in a whole-cell extract, with very similar broad distributions across
all major gene ontology categories for the three datasets (Figure S4). Analysis of fold-change data
(sua5/WT) for the sets of soluble and insoluble proteins revealed the following numbers of significantly
altered proteins (+30% fold-change relative to WT values, p < 0.05): 93 increased and 43 decreased
in the soluble fraction of the mutant, and 16 increased and 7 decreased in the insoluble fraction
(Table S2). An unexpected result from this analysis was the small number of proteins significantly
increased or decreased in the protein aggregates (i.e., insoluble) from the sua5 mutant compared to WT
cells. Given the evidence for “aggregation-prone” proteins and differential aggregation of proteins
based on physicochemical properties [76], we undertook an analysis of the properties associated
with the significantly up- and down-regulated proteins in the soluble and insoluble fractions from
WT and sua5 strains. As shown in Supplementary Figure S5, we found no significant differential
associations of protein fractions for isoelectric point (pI), codon adaptation index (CAI), protein size
(Da), protein half-life, hydrophobicity (GRAVY score), and abundance. Of note, the limited number
of significantly differentially expressed proteins in the insoluble fraction constrains the statistical
confidence of group-averaged physicochemical analyses of this group.
In light of the lack of physicochemical distinctions of the aggregated proteins in the sua5 mutant
and WT strains, we next analyzed the aggregated and soluble proteins for differences in function
and codon usage patterns. As shown in Table 2, there were significant enrichments in several GO
categories related to protein folding and stress response for up-regulated proteins in the soluble fraction.
A more granular look at specific proteins enriched in GO categories is shown in Table 3. Here we see
enrichment in mitochondrial assembly/function, protein quality processing/trafficking, oxidative stress
response, and energy homeostasis.
Table 2. Gene ontology (GO) category enrichment for soluble proteins that are overrepresented in sua5
relative to WT (Fold-change sua5/WT > 1.3) - Function.
Go Category

# Genes

P-Value

Protein binding involved in protein folding

7

6.53 × 10−8

Misfolded protein binding

7

4.24 × 10−7

Heat shock protein binding

7

3.37 × 10−6

ATPase activity, coupled

12

6.40 × 10−4

Purine ribonucleotide triphosphate binding

25

1.23 × 10−3

Unfolded protein binding

8

2.08 × 10−3

Table 3. Summary of soluble proteins that are significantly (p < 0.05) overrepresented in sua5 relative
to WT and map to enriched GO categories.
Protein

ORF

Description

Fold-Change

Mitochondrial heat shock
protein, SSC3

YEL030W

Refolding imported precursors

3.0

rRNA methyltransferase 2,
mitochondrial

YGL136C

Peptidyl transferase domain

2.3

Exosome complex component
RRP40

YOL142W

Exoribonuclease

1.9

Mitochondrial heat-shock
protein SSC1

YJR045C

Binds to precursor preprotein

1.8

Interacting with cytoskeleton
protein 1 ICY1

YMR195W

Required for the viability of cells lacking
mtDNA

1.7

Plasma membrane ATPase 2

YPLO36W

Nutrient active transport by H+ symport

1.7
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Table 3. Cont.
Protein

ORF

Description

Fold-Change

rRNA-processing protein CGR1

YGL029W

Involved in nucleolar integrity, required for
processing 60S pre-RNA

1.7

Mitochondrial import receptor
subunit TOM5

YPR133W-A

Component of receptor complex responsible for
recognizing, translocating cytosolically
synthesized mitochondrial preproteins

1.7

Endoplasmic reticulum
chaperone BiP (aka KAR2)

YJL034W

Role in facilitating assembly of multimeric
protein complexes in ER—required for
secretory polypeptide translocation

1.7

Cytochrome b-c1 complex
subunit 10 QCR10

YHR001W-A

Part of the mitochondrial respiratory chain that
generates electrochemical potential coupled to
ATP synthesis

1.7

V-Type proton ATPase subunit B

YBR127C

Non-catalytic subunit of V-ATPase:
electrogenic proton pump generating proton
motive force of 180 mV

1.7

Sulfiredoxin

YKL086W

Contributes to oxidative stress resistance by
reducing cysteine-sulfinic acid formed by
oxidants in the peroxiredoxin TSA1

1.6

Vacuolar morphogenesis protein
10

YOR068C

Required for vacuolar fusion; involved in the
early steps of the fusion pathway

1.6

Threonine-tRNA ligase,
mitochondrial

YKL194C

-

1.6

Mitochondrial peroxiredoxin
PRX1

YBL064C

Involved in mitochondrial protection from
oxidative stress

1.6

Inheritance of peroxisomes
protein 1

YMR204C

Inhibition of peroxisomes

1.6

Elongation factor 3A

YLR249W

Release of deacylated tRNA from ribosomal
E-site during synthesis

1.6

Heat shock protein SSA2

YLLO24C

Transport polypeptides both across the
mitochondrial membranes and into the ER

1.6

Glutathione peroxidase-like
peroxiredoxin 2 GPX2

YBR224W

Protects cells from phospholipid
hydroperoxides and nonphospholipid
peroxides during oxidative stress

1.6

Glutathione peroxidase-like
peroxiredoxin HYR1

YIRO37W

Oxidative stress response pathway

1.4

ATP synthase subunit f,
mitochondrial

YDR377W

Mitochondrial membrane ATP synthase

1.4

Heat shock protein SSA1

YALOO5C

Role in the transport of polypeptides both
across the mitochondrial membranes and into
the endoplasmic reticulum

1.4

Given the association of t6 A at position 37 of tRNAs that read ANN codons, we performed
an analysis of the codon usage patterns in up- and down-regulated proteins in the soluble and insoluble
fractions (sua5/WT). Figure 5A shows the scores plot in a principal components analysis of the 10 most
up-regulated proteins (red) in the soluble fraction from the sua5 mutant (relative to WT) and the 10
most down-regulated soluble proteins (green), with a clear segregation of the up- and down-regulated
proteins highlighted by the dotted line. While there is no clear bias in the use of t6 A-dependent ANN
codons in the loadings plot (brown circles in Figure 5B), there are several pairs of synonymous codon
partners that strongly distinguish the up- and down-regulated proteins (Figure 5B): ProCCG/down
and ProCCA/up; SerTCC/down and SerAGC-AGT/up; HisCAC/down and HisCAT/up; AlaGCG/down
and AlaGCT/up; ArgAGG/down and ArgAGA/up; IleATA/down and IleATT/ATC/up; GlyGGC/down
and GlyGGT/up. We have observed this type of biased use of synonymous codon pairs in differentially
regulated genes in yeast, bacteria, and human cells, with a strong link to coordinated changes in the
tRNA pool and tRNA wobble modifications [77–81].
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Figure 5. Partial least squares regression analysis of the association of codon usage with up- and
down-regulated proteins in cells lacking Sua5. Soluble (A,B) and insoluble proteins (C,D) were isolated
from wild-type and sua5 strains of S. cerevisiae and subjected to quantitative proteomics analysis. Codon
usage in the 10 most up- and down-regulated proteins in the sua5 strain compared to wild-type was
quantified using the codon utilization tool [82]. Partial least squares regression analysis was performed
on the proteomic fold-change values and the codon usage data, with the resulting scores plots (A,C) and
loadings plots (B,D) colored as follows: red, up-regulated proteins; green, down-regulated proteins;
gold circles, ANN codons read by t6 A-containing tRNAs; dotted line highlights the distinction between
up- and down-regulated proteins. Some proteins from the scores plot (those that do no mask codons)
are transposed to the loadings plot to highlight codon associations.

Parallel codon usage behavior was observed in the insoluble proteins in the sua5 mutant, with no
apparent bias in the use of t6 A-dependent ANN codons in up- and down-regulated proteins. As shown
in the scores plot in Figure 5C, the 10 most significant up- and down-regulated proteins in the insoluble
fraction are distinguished from each other, though not as clearly as the soluble fraction. The loadings
plot in Figure 5D shows the codon biases most strongly associated with the up- and down-regulated
proteins: AlaGCG/down and AlaGCC/up; ArgCGC/down and ArgCGT/up; and AspGAT/down and
AspGAC/up.
We have analyzed the codon biases for open reading frames corresponding to the up-regulated
proteins in the insoluble and down-regulated proteins in the soluble fraction, and while there were
notable biases (Figure 6), clear linkages to ANN codons were not identified. We have observed that there
are a distinct set of proteins whose open reading frames (ORFS) only contain ANN codons for arginine
(AGA and AGG) and STRING analysis has identified gene ontology (GO) terms (ATP metabolic process,
purine ribonucleoside monophosphate metabolic process, ribonucleoside monophosphate metabolic
process, electron transport chain, purine ribonucleotide metabolic process, oxidative phosphorylation,
ribonucleotide metabolic process, ribose phosphate metabolic process, mitochondrial ATP synthesis
coupled electron transport) that detail mitochondrial based ATP production and ribonucleoside
synthesis are significantly enriched (p < 10–9 ) (Table 4). We also analyzed all yeast ORFs to identify
how many contain AGN-AGN dicodons (Figure S6A), with 2,995 containing 0, and the rest containing
anywhere from 1 to 14 of these dicodons. Further analysis of AGN-AGN dicodons was assessed in
ORFs only using ANN codons for arginine, with 211 of these containing 0 AGN-AGN dicodons and
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the remaining 57 containing 1 to 4 (Figure S6B). These results support the idea that most ORFs using
AGN-AGN dicodons also use the other codons for arginine (CGN).

Figure 6. Codon usage trends in groups of transcripts corresponding to proteins regulated in sua5
cells. (A) Insoluble proteins up-regulated (fold change > 1.2, p < 0.05) in sua5 cells have corresponding
transcripts that over-use AUU, ACG, AAC and AGA codons. (B) Soluble proteins down-regulated
(fold change < 0.7, p < 0.05) in sua5 cells have corresponding transcripts that over-use AAC and AAG
codons. The color-coded table describes the increased (yellow) or decreased (purple) codon frequency
changes in a group of regulated proteins relative to genome averages (Codon-Group - Codon-Genome ) for
each of 64 codons, with white boxes describing changes less than 0.05. The t6 A dependent codons are
the ones in the red-box.
Table 4. STRING functional enrichment analysis of genes that only use AGA or AGG codons for
arginine. The observed gene count is the number of genes from the target list found in each functional
category, with the background gene count describing the total number of genes found in the category.
GO Term ID

Term Description

Observed Gene
Count

Background Gene
Count

False Discovery
Rate

GO:0046034

ATP metabolic process

31

94

2.55 × 10−12

GO:0009167

purine ribonucleoside
monophosphate metabolic process

32

118

1.74 × 10−11

GO:0009161

ribonucleoside monophosphate
metabolic process

33

136

6.23 × 10−11

GO:0022900

electron transport chain

25

74

1.09 × 10−10

GO:0009150

purine ribonucleotide metabolic
process

32

147

1.29 × 10−09

GO:0006119

oxidative phosphorylation

18

39

2.27 × 10−09

GO:0009259

ribonucleotide metabolic process

33

162

2.27 × 10−09

GO:0019693

ribose phosphate metabolic process

35

182

2.27 × 10−09

GO:0042775

mitochondrial ATP synthesis
coupled electron transport

17

37

7.14 × 10−09

GO:0022904

respiratory electron transport chain

18

45

1
1.07 × 10−08

GO:0009117

nucleotide metabolic process

39

250

2.69 × 10−08

GO:1902600

proton transmembrane transport

25

108

4.38 × 10−08
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To summarize the proteomics results, the loss of t6 A resulted in global defects in protein
folding, with aggregated and soluble proteins sharing similar physicochemical properties and
use of t6 A-dependent codons (ANN) in parent transcripts. However, loss of t6 A caused a stress
response apparent as increased expression of mitochondrial assembly/function, protein quality
processing/trafficking, oxidative stress response, and energy homeostasis proteins in the soluble
fraction. This stress response was associated with non-ANN codon biases, which is consistent with our
previous studies of stress-induced codon-biased translation in yeast [77,78].
3.4. The Absence of t6 A Does Not Specifically Affect the Translation of Prion Proteins
In S. cerevisiae, the protein with the longest stretch of codons decoded by t6 A containing tRNAs is
SWI1 with its stretch of 31 Asn and Thr amino acids starting at position 7 of the protein (24]. Because
these repeats (90 nts) are longer than the RPFs (28 nts) sequenced, this gene could not be analyzed
in the ribosome profiling that compared WT and t6 A- strains [36]. We set out to study if the absence
of t6 A affects the translation of proteins with long stretches of codons decoded by t6 A-dependent
tRNAs by constructing the plasmid pJMB21, which allowed for the expression of proteins containing
an N-terminal HA-tag with a C-terminal GFP fusion. The N-terminal end of SWI1 (residues 1–556)
was then inserted between the HA and GFP tag (Figure 7A,B). By Western blot, we compared the
expression of the HA-SWI1-GFP fusion from pJMB21::SWI1 in the t6 A single mutants gon7 and sua5 to
the wild-type (WT) strain. And the HA-GFP fusion, expressed from pJMB21, was used as a control. In
this experiment, we introduced the gon7 mutant, whose deleted gene is part of the KEOPS complex
and participates in the last step of t6 A formation. This strain is not as crippled as the sua5 strain
and allowed us to compare two different t6 A mutants. The expression of both fusions was detected
with an anti-HA tag antibody in all three strains at the expected molecular weight (HA-SWI1-GFP
with 95 kDa and HA-GFP with 33 kDa), meaning that the fusions are expressed in the WT and in the
t6 A mutants with no truncation. The intensity of the bands expressed from the t6 A mutant strains
was visually lower than the band from the WT strain, usually not detected within 1 h of membrane
exposure (Figure 7C). We used Image J [83] to calculate the intensity of the bands from a 3 h exposed
film. The area of the band was measured in the film and normalized based on the intensity of the
respective lane in a Coomassie-stained gel run in parallel and converted to percentage considering the
band intensity from the WT strain as 100% (Figure 7D). There is a smaller amount of both fusions in the
t6 A mutants compared to the WT, consisting of an approximately 80% reduction of the HA-SWI1-GFP
fusion and 40–55% reduction of the HA-GFP fusion. While the gels for [35 S]-labeling studies in Figure
S3 appear to show similar protein levels in the three strains, visual interpretation of the gels is not
accurate enough to distinguish modest changes in global translation. The more quantitative Western
blots in Figure 7 show evidence that the absence of t6 A modification reduces global translation by
~2-fold, at least for one representative non-codon-biased protein. This is consistent with our published
ribosome profiling studies [39]. However, loss of t6 A causes a larger reduction in the translation of
proteins enriched in t6 A dependent codons such as this SWI1 fragment.
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Figure 7. Detection of SWI1 fusion in t6 A deficient strains. (A) Representation of plasmid constructs
for protein expression in S. cerevisiae. pJMB21::SWI1 has a SWI1 fragment flanked by HA and GFP
tags (N- and C-terminal, respectively). pJMB21 is used as a control plasmid and expresses the HA tag
directly fused to the GFP tag. (B) Amino acid sequence of the expressed SWI1 fragment enriched in
stretches of the t6 A dependent codons Asn (N) and Thr (T). (C) Western blot detection of both fusions
with an anti-HA tag antibody in WT, sua5 and gon7 strains. This is a representative gel of three different
experiments performed with independent transformants. (D) Image J calculation of band intensities
from a 3 h exposed film. The band intensities were converted to percentage considering, for each fusion,
the WT strain intensity as 100%.

4. Discussion
The ASL modifications (c)t6 A and mcm5 (s2 )U, found in yeast tRNAs respectively at positions 37
and 34, are critical for correct pre-structuring of the ASL [13–17]. Severe diseases in humans [18–22] and
very similar phenotypes in yeast S. cerevisiae [3,29,37] are observed as a result of deficiencies in both these
modifications. The sua5 elp3 mutant (lacking both t6 A and mcm5 U modifications), is viable in the YPD
medium but cannot grow in the presence of various exogenous stressors such as elevated temperature,
diamide or alternative carbon sources. Additionally, combined sua5 and elp3 mutations are synthetically
negative, with the sua5 elp3 double mutant presenting slower growth, morphological defects and
mis-segregated nuclei compared to the elp3 and sua5 single mutants, resembling observations in
other strains lacking critical anticodon loop modification simultaneously [29,84]. The absence of ASL
modifications frequently affects translation speed and accuracy [4,39] leading to +1 frameshifting
and misreading at specific codons [24,43,72]. Here we showed that t6 A and mcm5 U modifications
contribute independently to reading frame maintenance and that their absence has an additive effect
on ribosomal accuracy.
Previously, the absence of mcm5 s2U or t6 A in yeast was shown to induce the formation of
protein aggregates [4,39]. In the present study, we detected a drastic increase in the amount of
protein aggregates in the double mutant by two different methods. The presence of aggregates in
morphologically aberrant cells, encompassing two or more of the non-separated individual cells may
indicate that aggregate formation and extension from the mother into the daughter cell may contribute
to the repeated failures in cytokinesis. Hence, synthetic growth defects in sua5 elp3 and aberrant
morphology occur along with increased protein aggregation and indications for cumulative A-site
binding defects, pointing to the interdependency of these events.
Cells defective in Elongator, tRNA thiolation, and t6 A modification commonly upregulate gene
expression of Gcn4 dependent amino acid biosynthesis [3,9,39]. Gupta et al. [85] have shown that, for
the tRNA thiolation defective mutant, the Gcn4 activation occurs despite the presence of elevated
levels of amino acids, including Met and Cys. If this activation also occurs in sua5 and sua5 elp3 strains,
the reduced incorporation of [35 S] in proteins from these mutants could be a result of elevated levels
of endogenous Met and Cys, which might account for reduced label incorporation via exogenous
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radiolabeled Met and Cys. Therefore, these results do not allow us to draw conclusions about tRNA
modification-dependent protein aggregation and translation.
The quantitative proteomics of the soluble and insoluble fractions of the t6 A mutant (sua5
strain) shed light on the altered biological processes resulting from t6 A absence. Among the
up-regulated proteins in the mutant soluble fraction, there is an enrichment of proteins related to
oxidative stress response, protein quality processing/trafficking, energy homeostasis, and mitochondrial
assembly/function. The effect of t6 A modification has been shown in human mitochondrial tRNAs
(mt-tRNAs) [86] where the lack of OSGEPL1, the human homolog of yeast Qri7 involved in t6 A
formation in mt-tRNAs, resulted in reduced mitochondrial protein synthesis, impaired assembly of
Complex I and respiratory defects. These effects could be a result of a dysfunction in the mitochondrial
translation of the proteins ND2 and ND5, components of Complex I that contain higher frequencies of
codons decoded by the five mt-tRNAs bearing t6 A modification.
A more detailed analysis of the insoluble proteome of the t6 A mutant (sua5 strain) revealed
a surprisingly low number of proteins with increased or decreased abundance in aggregates in
the mutant compared to the WT strain, considering the expected “aggregation-prone” strain. But
a closer look at the identity of the proteins enriched in the insoluble fraction revealed potentially
interesting findings that will require follow-up studies. Among the proteins with increased abundance
in the mutant aggregates, some are related to transcription regulation (histones H2A.2 and H2B.1,
and negative cofactor 2 transcription regulator complex subunit NCB2), mitochondrial function
(ubiquinol-cytochrome-c reductase subunit 7 QCR7) and oxidative stress resistance (thioredoxin
peroxidase AHP1). Levels of [PIN+] prion protein RNQ1 were slightly increased in the aggregate pool
in the mutant (1.4-fold increase, p = 0.07). These results suggest that the absence of t6 A modification
could affect the translation of prion proteins, as observed for SWI1.
Containing an N-terminal stretch of 31 Asn and Thr amino acids, the prion protein SWI1 is the
protein with the longest stretch of codons decoded by t6 A containing tRNAs in S. cerevisiae [24,51].
The detection of a fusion containing a SWI1 fragment fused to HA and GFP tags, revealed that even
a protein enriched in such high number of t6 A dependent codon stretches is fully translated in the
absence of t6 A (sua5 and gon7 strains), although there is a marked reduction in protein expression levels.
The comparison of the HA-SWI1-GFP fusion expression to its control, HA-GFP, showed that t6 A absence
has a global effect on expression (40–55% reduction of HA-GFP compared to the WT) and an even
more drastic effect on the expression of proteins enriched in t6 A dependent codons (80% reduction
of HA-SWI1-GFP compared to the WT). This marked reduction in the overexpressed SWI1 fragment
contrasted with the non-significant alteration in levels of the endogenous expression of SWI1, showing
in the proteomics analysis an 8% decrease in the soluble fraction and a 2% decrease in the insoluble
fraction of the sua5 strain (Table S2). Because we obtained these results using Western blot, a not a very
sensitive technique, and because we did not quantify mRNA levels and hence cannot differentiate
between transcription and translation effects, these findings need to be confirmed in future studies. We
also need to analyze if this drastic effect in the mutant is due to reduced translation or formation of
aggregates caused by misfolded proteins, or even prion formation. A reason overproduction could
induce prion formation is that the increase in protein level could make it more likely for misfolding
events to occur [87]. At higher local concentration it would be easier for monomers to find each other
and aggregate. Prion domains (PrDs) may also be more likely to misfold when they are not in the
context of the complete protein. Additionally, the increased protein levels may cause the misfolded
protein to escape degradation by proteolytic pathways [87]. In the case of SWI1, its overproduction
can also induce the formation of the Sup35 prion [PSI+] [50]. It is therefore difficult to predict whether
t6 A deficiency is detrimental or beneficial for prion formation.
5. Conclusions
In summary, this study showed how the critical tRNA modifications t6 A37 and mcm5 s2 U34
contribute to the maintenance of proteome integrity of the model yeast S. cerevisiae by demonstrating
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the effects caused by the deficiency of both modifications in the cell. While elevated +1 frameshift levels
were observed in single sua5 and elp3 mutants (t6 A- and mcm5 s2 U-deficient, respectively) showing
that each modification independently contributes to the reading frame maintenance, a further increase
in +1 frameshift levels in the sua5 elp3 double mutant demonstrated an additive translation defect.
Synthetic phenotypes in the double mutant such as slower sporulation, enhanced growth defect,
aberrant morphology, and synthetic lethality to various exogenous stressors reinforced the additive
and possibly synergistic translation defects. The combined translation defects resulting from the lack of
both modifications reflect also in the formation of protein aggregates in the cell. Although aggregates
have been previously detected in the single mutants, a strong increase was observed in the double
mutant, particularly in morphologically aberrant cells. Proteomics of the sua5 single mutant indeed
revealed an increase in the abundance of proteins associated with protein folding and trafficking, as
well as with mitochondrial function, oxidative stress response, and energy homeostasis in t6 A-deficient
strain. These results point to a global mistranslation effect leading to protein aggregation, although
without regard to t6 A-dependent or biased codon usage in parent genes. This work reinforces the
importance of the complex modification of the ASL in assuring the accuracy and efficiency of the
translation process.
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